Please use this identifier to cite or link to this item:
|Title:||Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer|
Rosell Costa, R.
Monzó Planella, Mariano
Anta i Vinyals, Josep Maria de
Sánchez, J. J.
Mate, José L.
Sánchez Céspedes, Montserrat
|Keywords:||Duplicació de l'ADN|
Síntesi de l'ADN
Càncer de pulmó
|Publisher:||Cancer Research UK|
|Abstract:||As chromosomes 2p and 3p are frequent targets for genomic instability in lung cancer, we have addressed whether alterations of simple (CA)n DNA repeats occur in non-small-cell lung cancer (NSCLC) at early stages. We have analysed by polymerase chain reaction (PCR) assay replication errors (RER) and loss of heterozygosity (LOH) at microsatellites mapped on chromosomes 2p and 3p in 64 paired tumour-normal DNA samples from consecutively resected stage I, II or IIIA NSCLC. DNA samples were also examined for K-ras and p53 gene mutations by PCR-single-stranded conformational polymorphism (PCR-SSCP) analysis and cyclic sequencing, as well as their relationship with clinical outcome. Forty-two of the 64 (66%) NSCLC patients showed RER at single or multiple loci. LOH was detected in 23 tumours (36%). Among patients with stage I disease, the 5-year survival rate was 80% in those whose tumours had no evidence of RER and 26% in those with RER (P = 0.005). No correlation was established between RER phenotype and LOH, K-ras or p53 mutations. RER remained a strong predictive factor (hazard ratio for death, 2.89; 95% confidence interval, 2.23-3.79; P = 0.002) after adjustment for all other evaluated factors, including p53, K-ras, LOH, histological type, tumour differentiation and TNM stage, suggesting that microsatellite instability on chromosomes 2p and 3p may play a role in NSCLC progression through a different pathway from the traditional tumour mechanisms of oncogene activation and/or tumour-suppressor gene inactivation.|
|Note:||Reproducció del document publicat a: https://doi.org/10.1038/bjc.1997.31|
|It is part of:||British Journal of Cancer, 1997, vol. 75, num. 2, p. 184-189|
|Appears in Collections:||Articles publicats en revistes (Patologia i Terapèutica Experimental)|
Files in This Item:
|110527.pdf||1.09 MB||Adobe PDF||View/Open|
This item is licensed under a Creative Commons License